Clinical Read2026-06-15

Epcoritamab (Epcor) - (EPCORE DLBCL-1)

Genmab A/SGMAB
Indication
Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL)
Stage
phase3
Event
Phase 3